Brief: EQL Pharma Q2 EBIT SEK 6.6 Million
17/11/2023 06:00
Nov 17 (Reuters) - EQL Pharma Q2 adjusted free cash flow SEK -4 million. * Q2 EBIT margin 11% * Q2 adjusted revenue SEK 59.6 million * Q2 revenue SEK 59.6 million
EQL — EQL Pharma AB News Story
0.000.00%
Last trade - 00:00- SEK670.32m
- SEK1.07bn
- SEK432.66m